尿CD4+T细胞可预测ANCA相关血管炎肾脏复发
PRE-FLARED前瞻性多中心生物标志物研究纳入102例缓解期ANCA相关血管炎患者,用流式细胞术定量基线尿CD4+T细胞亚群并随访6个月。尿CD4+T细胞预测肾脏复发的AUC为0.88,以每100ml尿490个为切点,敏感度60%、特异度97.8%,优于ANCA滴度、血尿和蛋白尿。
要点
- 尿CD4+T细胞可预测6个月内肾脏复发,AUC 0.88。
- 切点490个/100ml尿时敏感度60%、特异度97.8%。
- 联合PR3-ANCA或可改善PR3+亚组预测。
核心结论
- 尿CD4+T细胞计数可识别6个月内肾脏复发风险较高的ANCA相关血管炎患者。
- 尿CD4+T细胞联合ANCA水平可进一步改善复发预测。
研究设计与样本
- PRE-FLARED为前瞻性多中心生物标志物研究,纳入102例缓解期ANCA相关血管炎患者。
- 基线用流式细胞术定量尿CD4+T细胞亚群,随访6个月观察临床结局。
主要发现
- 102例中10例发生肾脏复发、2例非肾脏复发、90例维持稳定缓解。
- 复发患者基线尿CD4+T细胞计数中位数显著高于缓解者。
- 尿CD4+T细胞计数预测肾脏复发的ROC曲线AUC为0.88,优于ANCA滴度、血尿和蛋白尿。
- 以每100ml尿490个CD4+T细胞为切点,预测未来肾脏复发的敏感度60%、特异度97.8%。
- 事后分析提示尿CD4+T细胞计数联合蛋白酶3-ANCA水平可能改善PR3+亚组的预测性能。
关键数值与推荐
- 尿CD4+T细胞预测肾脏复发AUC为0.88。
- 切点490个CD4+T细胞/100ml尿时敏感度60%、特异度97.8%。
临床怎么用
- 可监测缓解期ANCA相关血管炎患者尿CD4+T细胞以评估6个月内肾脏复发风险。
- 高尿CD4+T细胞计数者或可及早采取预防措施并制定个体化治疗策略。
局限性
- 尿CD4+T细胞数量与随访期间GFR下降和蛋白尿增加的关联有限。
- 联合蛋白酶3-ANCA改善预测性能的结果来自事后分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: Early identification of patients at risk of renal flares in ANCA vasculitis is crucial. However, current clinical parameters have limitations in predicting renal relapse accurately. This study investigated the use of urinary CD4 + T lymphocytes as a predictive biomarker for renal flares in ANCA vasculitis. This study, including urine samples from 102 patients, found that the presence of urinary CD4 + T cells was a robust predictor of renal relapse within a 6-month time frame, with a sensitivity of 60% and a specificity of 97.8%. The diagnostic accuracy of urinary CD4 + T cells exceeded that of ANCA titers, proteinuria, and hematuria. Monitoring urinary CD4 + T lymphocytes could help assess the risk of future renal relapse, enabling early preventive measures and tailored treatment strategies. BACKGROUND: In ANCA-associated vasculitis, there is a lack of biomarkers for predicting renal relapse. Urinary T cells have been shown to differentiate active GN from remission in ANCA-associated vasculitis, but their predictive value for renal flares remains unknown. METHODS: The PRE-FLARED study was a prospective multicenter biomarker study including 102 individuals with ANCA-associated vasculitis in remission aimed to predict renal relapse by quantifying urinary CD4 + T-cell subsets using flow cytometry at baseline and monitoring clinical outcomes over a 6-month follow-up. RESULTS: Among the participants, ten experienced renal relapses, two had non-renal flares, and 90 remained in stable remission. The median baseline urinary CD4 + T-cell count was significantly higher in patients who relapsed compared with those in remission. Receiver operating characteristic curve analysis of urinary CD4 + T-cell counts showed an area under the curve value of 0.88 for predicting renal flares, outperforming ANCA titers, hematuria, and proteinuria. Using a cutoff of 490 CD4 + T cells per 100 ml urine, the sensitivity and specificity in identifying patients with future renal flares were 60% and 97.8%, respectively. In a post hoc analysis, combining urinary CD4 + T-cell counts with proteinase-3 ANCA levels suggested improved predictive performance in the PR3 + subgroup. In addition, the number of urinary CD4 + T cells showed a limited correlation with a decline in GFR and an increase in proteinuria over the follow-up period. CONCLUSIONS: This study concluded that urinary CD4 + T-cell counts could identify patients with ANCA-associated vasculitis at a substantial risk of renal relapse within 6 months. Combining these counts with ANCA levels further improved the prediction of relapse. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis (PRE-FLARED), NCT04428398 .
引用
- Prskalo L, Skopnik CM, Goerlich N, et al. Urinary CD4 + T Cells Predict Renal Relapse in ANCA-Associated Vasculitis. J Am Soc Nephrol. 2024. PMID: 38231590. doi:10.1681/ASN.0000000000000311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。